Trauma may be even more complex than previously thought. Post-traumatic stress disorder (PTSD) is often portrayed in popular ...
These data represent one of the largest clinical development programs to date for adults living with PTSD and a significant development in a therapy area that hasn’t seen a new approval for a ...
LONDON & NEW YORK, January 07, 2026--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, today ...
Compass Pathways has navigated to another successful midphase readout, linking its psilocybin therapy and psychological support to improvements in post-traumatic stress disorder (PTSD) in a small ...
Many people have interpreted as a setback the “no” vote by an advisory committee to the Food and Drug Administration on Lykos Therapeutics’ new drug application for MDMA-assisted psychotherapy for ...
Clinical trial launched to explore new drug treatments for military personnel and veterans with PTSD
A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD). The ...
Rena Goldman has over a decade of writing and editing experience. She covers health, wellness, mental health, small business, and how politics and policies impact our daily lives. Rena has worked as a ...
FDA Accepts Investigational New Drug (IND) Application for COMP360 for the treatment of post-traumatic stress disorder (PTSD), enabling initiation of late-stage trial Compass continues to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback